GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.

Epithelial sodium channel (ENaC): Introduction

Epithelial sodium channels (ENaC) are located on the apical membrane of epithelial cells in the kidney tubules, lungs, respiratory tract, male and female reproductive tracts, sweat and salivary glands, placenta, colon, and several other organs [9,16,24-25,53]. In these epithelia, Na+ ions enter epithelial cells from the extracellular fluid via ENaC and are subsequently pumped out into the interstitial fluid by the Na+/K+-ATPase on the basolateral membrane [45]. Because sodium is a major electrolyte in the extracellular fluid (ECF), the osmotic changes caused by sodium flux are accompanied by parallel water movement [7]. Thus, ENaC plays a central role in regulating ECF volume and blood pressure, primarily through its function in the kidney [47]. The expression of ENaC subunits- and therefore its activity- is controlled by the renin-angiotensin-aldosterone system and other factors involved in electrolyte homeostasis [33,47].

Genetic studies of systemic pseudohypoaldosteronism type I revealed that ENaC activity depends on three essential subunits encoded by three separate genes encoding homologous proteins [11,25]. Within the wider protein superfamily that includes ENaC, the first crystal structure determined was that of ASIC, which revealed a trimeric structure with a large extracellular domain anchored in the membrane by a bundle of six transmembrane helices (two per subunit) [3,28]. The first 3D structure of human ENaC was determined using single-particle cryo-electron microscopy at 3.7Å resolution [41], later improved to 3.0Å [42]. These structures confirmed that ENaC has a quaternary structure similar to ASIC. ENaC assembles as a heterotrimer, with α-, γ-, and β-subunits arranged in clockwise order when viewed from above [12]. In contrast to ASIC1, which can form a functional homotrimer, ENaC is only fully functional as a heterotrimer composed of either αβγ or δβγ [30]. Recently, Houser and Baconguis co-expressed human δ, β, and γ and determined the structures of complexes using single-particle cryoelectron microscopy. The structures showed that β and γ positions are conserved among the different complexes while the α position in the αβγ trimer is occupied by either δ or another β [27].

In the respiratory and female reproductive tracts, large regions of the epithelium consist of multiciliated cells with a microtubule-based cytoskeleton. In these cells, ENaC is distributed along the entire length of the cilia [18]. This localization substantially increases ENaC density on the cell surface and enables precise regulation of periciliary fluid osmolarity throughout its depth [18]. In the vas deferens of the male reproductive tract, the luminal surface is covered with microvilli and stereocilia supported by actin bundles [53]. In these cells, both ENaC and the aquaporin AQP9 are localized to the projections as well as to the basal and smooth muscle layers [53]. In contrast, CFTR- the chloride channel defective in cystic fibrosis- is confined to the apical cell surface but is absent from cilia and microvilli [18,53]. Collectively, ENaC function regulates epithelial fluid volume, which is essential for mucociliary clearance in the respiratory tract, gamete transport, fertilization, implantation, and cell migration [18,25,40].

Genes and Phylogeny
The human genome contains four homologous genes (SCNN1A, SCNN1B, SCNN1G, and SCNN1D) encoding the α-, β-, γ-, and δ-ENaC subunits, respectively [10,37,51,58]. These subunits share 23-34% sequence identity and <20% identity with ASIC subunits [25]. Genes encoding all four ENaC subunits are present in bony vertebrates, except in ray-finned fishes, which have lost them entirely. The mouse genome has also lost SCNN1D, the gene for δ-ENaC [20,25]. The α-, β-, and γ-ENaC genes are present in jawless vertebrates (e.g., lampreys) and cartilaginous fishes (e.g., sharks) [25].

Methylation analysis of the 5′-flanking regions of SCNN1A, SCNN1B, and SCNN1G in human cells revealed an inverse correlation between gene expression and DNA methylation, suggesting epigenetic transcriptional control of ENaC genes [44].

Channel biogenesis, assembly and function
ENaC subunit expression is regulated primarily by aldosterone and by numerous other extracellular and intracellular factors [32,43,47]. Most studies indicate that expression of the three subunits is not tightly coordinated [8]. However, transport of the subunits to the membrane requires all three intact subunits, and even a single missense mutation can reduce the number of assembled channels on the cell surface [17].

ENaC is constitutively active, meaning Na+ flow does not require an activating factor. Thus, heterologous cells expressing ENaC (e.g., human cRNAs in Xenopus oocytes) must be maintained in amiloride-containing solutions to block channel activity. ENaC activity is then measured by replacing the bath with amiloride-free solution. The channel alternates between two states: 1) open and 2) closed. The probability of ENaC being open is referred to as open probability (Po). ENaC regulation involves two key parameters: (1) membrane channel density and (2) open probability [29-30]. Open probability is markedly reduced by extracellular Na+ in a process known as sodium self-inhibition [4,26,55].

A key regulatory feature is that the α- and γ-subunits contain conserved extracellular serine protease cleavage sites [25]. Proteolytic cleavage by enzymes such as furin and plasmin activates ENaC [1,31,48].

Diseases associated with ENaC mutations
Mutations in SCNN1A, SCNN1B, or SCNN1G can cause partial or complete loss of ENaC activity [11,22]. Such loss-of-function mutations are associated with systemic or multi-system autosomal recessive pseudohypoaldosteronism type I (OMIM abbreviation: PHA1B) [11,18,21,25,50,60]. No PHA-causing mutations have been identified in SCNN1D. Patients with PHA experience severe salt wasting in all aldosterone target organs expressing ENaC, including kidney, sweat glands, salivary glands, and respiratory tract. In infancy and early childhood, the resulting electrolyte disturbances, dehydration, and acidosis often require recurrent hospitalization. The frequency and severity of salt-wasting episodes generally improve with age [23]. PHA1B also affects female reproductive system function [6,18].

The ENaC carboxy-terminal region contains a short consensus sequence called the PY motif. Mutations in this motif in SCNN1B and SCNN1G are associated with Liddle syndrome, a disorder marked by early-onset hypertension [5,56]. The PY motif is recognized by Nedd4-2, a ubiquitin ligase. Mutations that disrupt this recognition reduce ENaC ubiquitylation, leading to channel accumulation at the membrane and increased ENaC activity [49].

ENaC expression in tumors
Intracellular sodium concentrations are often elevated in cancer cells compared with normal cells, leading to the hypothesis that ENaC overexpression may contribute to metastasis [36]. However, RNA-seq analysis of ENaC genes and clinical data of cervical cancer patients from The Cancer Genome Atlas (TCGA) revealed a negative correlation with histologic grades of tumor [57]. Similarly, in breast cancer cells, overexpression or siRNA-mediated knockdown of α-ENaC showed that higher α-ENaC levels suppress cell proliferation [59]. In contrast, TCGA data showed that elevated SCNN1A expression correlates with poor prognosis in ovarian cancer [38]. Thus, the role of ENaC in tumorigenesis appears to be tissue-specific.

COVID-19
SARS-CoV-2 virions, the cause of COVID-19, are covered with glycosylated spike (S) proteins. These proteins bind to membrane-bound ACE2 as the first step of viral entry. Entry depends on S-protein cleavage (at Arg-667/Ser-668) by a serine protease. Anand et al. identified a sequence motif at this cleavage site homologous to the furin cleavage site in ENaCα [2]. A comprehensive review of COVID-19 pathophysiology suggests a role for ENaC in the early stages of infection in respiratory epithelia [19].

ENaC Inhibitors for Cystic Fibrosis
Cystic fibrosis (CF) is the most common life-limiting autosomal recessive disorder among Caucasians. CF is caused by mutations in the gene that codes for CFTR (Cystic Fibrosis Transmembrane Conductance Regulator). CFTR is a chloride and bicarbonate channel located on the apical membrane [13]. CFTR-mediated movement of Cl- and HCO3- ions into the lumen also drives water flow into the lumen by osmosis. CFTR is expressed in many tissues but the most severe effect of mutated CFTR is observed in the respiratory tract in the form of airway surface liquid (ASL) depletion which leads to mucus accumulation, inflammation and bacterial infections that lead to mortality.

Normal CFTR activity inhibits ENaC by causing a reduction in surface expression of ENaC as well as its Po [46]. In many epithelia, ENaC and CFTR are not co-localized on the apical membrane indicating that the two channels do not directly interact [18,52-53]. In the absence of a functional CFTR, ENaC activity increases (also named as "hyperactivated ENaC"), leading to increased Na+ and water absorption and consequently ASL depletion. These observations have led to the development of inhibitors targeting ENaC in the airways to ameliorate ASL dehydration [35,39,54]. Most of the ENaC inhibitors in development are designed for application by inhalation and improved lung retention to avoid damaging the vital activity of ENaC in other tissues [15,34]. Despite the development of many ENaC inhibitors for CF [14], nearly all drug candidates were discontinued at Preclinical, Phase 1 or Phase 2 stage of clinical trials [15,35,39]. However, there is one candidate, EDT001, that is still under Phase 2 clinical trial [15]. The persistence of the scientists and the drug companies and the versatility of their approaches provide hope that an appropriate useful treatment will emerge to help CF patients.

Thus, insights into the physiological and pathological roles of ENaC across diverse tissues continue to guide the development of targeted inhibitors, with cystic fibrosis representing a prominent example where modulation of ENaC activity may translate fundamental biology into therapeutic benefit.

References

Show »

1. Anand D, Hummler E, Rickman OJ. (2022) ENaC activation by proteases. Acta Physiol (Oxf), 235 (1): e13811. [PMID:35276025]

2. Anand P, Puranik A, Aravamudan M, Venkatakrishnan AJ, Soundararajan V. (2020) SARS-CoV-2 strategically mimics proteolytic activation of human ENaC. Elife, 9. DOI: 10.7554/eLife.58603 [PMID:32452762]

3. Baconguis I, Bohlen CJ, Goehring A, Julius D, Gouaux E. (2014) X-ray structure of acid-sensing ion channel 1-snake toxin complex reveals open state of a Na(+)-selective channel. Cell, 156 (4): 717-29. [PMID:24507937]

4. Bize V, Horisberger JD. (2007) Sodium self-inhibition of human epithelial sodium channel: selectivity and affinity of the extracellular sodium sensing site. Am J Physiol Renal Physiol, 293 (4): F1137-46. [PMID:17670907]

5. Bogdanović R, Kuburović V, Stajić N, Mughal SS, Hilger A, Ninić S, Prijić S, Ludwig M. (2012) Liddle syndrome in a Serbian family and literature review of underlying mutations. Eur J Pediatr, 171 (3): 471-8. [PMID:21956615]

6. Boggula VR, Hanukoglu I, Sagiv R, Enuka Y, Hanukoglu A. (2018) Expression of the epithelial sodium channel (ENaC) in the endometrium - Implications for fertility in a patient with pseudohypoaldosteronism. J Steroid Biochem Mol Biol, 183: 137-141. [PMID:29885352]

7. Bourque CW. (2008) Central mechanisms of osmosensation and systemic osmoregulation. Nat Rev Neurosci, 9 (7): 519-31. [PMID:18509340]

8. Butterworth MB, Weisz OA, Johnson JP. (2008) Some assembly required: putting the epithelial sodium channel together. J Biol Chem, 283 (51): 35305-9. [PMID:18713729]

9. Canessa CM, Merillat AM, Rossier BC. (1994) Membrane topology of the epithelial sodium channel in intact cells. Am J Physiol, 267 (6 Pt 1): C1682-90. [PMID:7810611]

10. Canessa CM, Schild L, Buell G, Thorens B, Gautschi I, Horisberger JD, Rossier BC. (1994) Amiloride-sensitive epithelial Na+ channel is made of three homologous subunits. Nature, 367 (6462): 463-7. [PMID:8107805]

11. Chang SS, Grunder S, Hanukoglu A, Rösler A, Mathew PM, Hanukoglu I, Schild L, Lu Y, Shimkets RA, Nelson-Williams C et al.. (1996) Mutations in subunits of the epithelial sodium channel cause salt wasting with hyperkalaemic acidosis, pseudohypoaldosteronism type 1. Nat Genet, 12 (3): 248-53. [PMID:8589714]

12. Collier DM, Snyder PM. (2011) Identification of epithelial Na+ channel (ENaC) intersubunit Cl- inhibitory residues suggests a trimeric alpha gamma beta channel architecture. J Biol Chem, 286 (8): 6027-32. [PMID:21149458]

13. Csanády L, Vergani P, Gadsby DC. (2019) STRUCTURE, GATING, AND REGULATION OF THE CFTR ANION CHANNEL. Physiol Rev, 99 (1): 707-738. [PMID:30516439]

14. Danahay H, Gosling M, Fox R, Lilley S, Charlton H, Hargrave JD, Schofield TB, Hay DA, Went N, McMahon P et al.. (2025) Optimisation of a novel series of ENaC inhibitors, leading to the selection of the long-acting inhaled clinical candidate ETD001, a potential new treatment for cystic fibrosis. Eur J Med Chem, 282: 117040. [PMID:39561495]

15. Danahay H, McCarthy C, Schofield T, Fox R, Charlton H, Lilley S, Sabater J, Salathe M, Baumlin N, Collingwood SP et al.. (2025) ETD001: A novel inhaled ENaC blocker with an extended duration of action in vivo. J Cyst Fibros, 24 (1): 72-78. [PMID:38851923]

16. Duc C, Farman N, Canessa CM, Bonvalet JP, Rossier BC. (1994) Cell-specific expression of epithelial sodium channel alpha, beta, and gamma subunits in aldosterone-responsive epithelia from the rat: localization by in situ hybridization and immunocytochemistry. J Cell Biol, 127 (6 Pt 2): 1907-21. [PMID:7806569]

17. Edelheit O, Ben-Shahar R, Dascal N, Hanukoglu A, Hanukoglu I. (2014) Conserved charged residues at the surface and interface of epithelial sodium channel subunits--roles in cell surface expression and the sodium self-inhibition response. FEBS J, 281 (8): 2097-111. [PMID:24571549]

18. Enuka Y, Hanukoglu I, Edelheit O, Vaknine H, Hanukoglu A. (2012) Epithelial sodium channels (ENaC) are uniformly distributed on motile cilia in the oviduct and the respiratory airways. Histochem Cell Biol, 137 (3): 339-53. [PMID:22207244]

19. Gentzsch M, Rossier BC. (2020) A Pathophysiological Model for COVID-19: Critical Importance of Transepithelial Sodium Transport upon Airway Infection. Function (Oxf), 1 (2): zqaa024. DOI: 10.1093/function/zqaa024 [PMID:33201937]

20. Giraldez T, Rojas P, Jou J, Flores C, Alvarez de la Rosa D. (2012) The epithelial sodium channel δ-subunit: new notes for an old song. Am J Physiol Renal Physiol, 303 (3): F328-38. [PMID:22573384]

21. Hanukoglu A. (1991) Type I pseudohypoaldosteronism includes two clinically and genetically distinct entities with either renal or multiple target organ defects. J Clin Endocrinol Metab, 73 (5): 936-44. [PMID:1939532]

22. Hanukoglu A, Edelheit O, Shriki Y, Gizewska M, Dascal N, Hanukoglu I. (2008) Renin-aldosterone response, urinary Na/K ratio and growth in pseudohypoaldosteronism patients with mutations in epithelial sodium channel (ENaC) subunit genes. J Steroid Biochem Mol Biol, 111 (3-5): 268-74. [PMID:18634878]

23. Hanukoglu A, Hanukoglu I. (2018) In systemic pseudohypoaldosteronism type 1 skin manifestations are not rare and the disease is not transient. Clin Endocrinol (Oxf), 89 (2): 240-241. [PMID:29702750]

24. Hanukoglu I, Boggula VR, Vaknine H, Sharma S, Kleyman T, Hanukoglu A. (2017) Expression of epithelial sodium channel (ENaC) and CFTR in the human epidermis and epidermal appendages. Histochem Cell Biol, 147 (6): 733-748. [PMID:28130590]

25. Hanukoglu I, Hanukoglu A. (2016) Epithelial sodium channel (ENaC) family: Phylogeny, structure-function, tissue distribution, and associated inherited diseases. Gene, 579 (2): 95-132. [PMID:26772908]

26. Horisberger JD, Chraïbi A. (2004) Epithelial sodium channel: a ligand-gated channel?. Nephron Physiol, 96 (2): p37-41. [PMID:14988660]

27. Houser A, Baconguis I. (2025) Structural insights into subunit-dependent functional regulation in epithelial sodium channels. Structure, 33 (2): 349-362.e4. [PMID:39667931]

28. Jasti J, Furukawa H, Gonzales EB, Gouaux E. (2007) Structure of acid-sensing ion channel 1 at 1.9 A resolution and low pH. Nature, 449 (7160): 316-23. [PMID:17882215]

29. Kashlan OB, Kleyman TR. (2012) Epithelial Na(+) channel regulation by cytoplasmic and extracellular factors. Exp Cell Res, 318 (9): 1011-9. [PMID:22405998]

30. Kellenberger S, Schild L. (2015) International Union of Basic and Clinical Pharmacology. XCI. structure, function, and pharmacology of acid-sensing ion channels and the epithelial Na+ channel. Pharmacol Rev, 67 (1): 1-35. [PMID:25287517]

31. Kleyman TR, Eaton DC. (2020) Regulating ENaC's gate. Am J Physiol Cell Physiol, 318 (1): C150-C162. [PMID:31721612]

32. Kleyman TR, Kashlan OB, Hughey RP. (2018) Epithelial Na+ Channel Regulation by Extracellular and Intracellular Factors. Annu Rev Physiol, 80: 263-281. [PMID:29120692]

33. Knepper MA, Kwon TH, Nielsen S. (2015) Molecular physiology of water balance. N Engl J Med, 372 (14): 1349-58. [PMID:25830425]

34. Kristensson C, Åstrand A, Donaldson S, Goldwater R, Abdulai R, Patel N, Gardiner P, Tehler U, Mercier AK, Olsson M et al.. (2022) AZD5634, an inhaled ENaC inhibitor, in healthy subjects and patients with cystic fibrosis. J Cyst Fibros, 21 (4): 684-690. [PMID:35227647]

35. Lemmens-Gruber R, Tzotzos S. (2023) The Epithelial Sodium Channel-An Underestimated Drug Target. Int J Mol Sci, 24 (9). [PMID:37175488]

36. Leslie TK, Brackenbury WJ. (2023) Sodium channels and the ionic microenvironment of breast tumours. J Physiol, 601 (9): 1543-1553. [PMID:36183245]

37. Lingueglia E, Voilley N, Waldmann R, Lazdunski M, Barbry P. (1993) Expression cloning of an epithelial amiloride-sensitive Na+ channel. A new channel type with homologies to Caenorhabditis elegans degenerins. FEBS Lett, 318 (1): 95-9. [PMID:8382172]

38. Lou J, Wei L, Wang H. (2022) SCNN1A Overexpression Correlates with Poor Prognosis and Immune Infiltrates in Ovarian Cancer. Int J Gen Med, 15: 1743-1763. [PMID:35221714]

39. Mall MA. (2020) ENaC inhibition in cystic fibrosis: potential role in the new era of CFTR modulator therapies. Eur Respir J, 56 (6). DOI: 0.1183/13993003.00946-2020 [PMID:32732328]

40. Matalon S, Bartoszewski R, Collawn JF. (2015) Role of epithelial sodium channels in the regulation of lung fluid homeostasis. Am J Physiol Lung Cell Mol Physiol, 309 (11): L1229-38. [PMID:26432872]

41. Noreng S, Bharadwaj A, Posert R, Yoshioka C, Baconguis I. (2018) Structure of the human epithelial sodium channel by cryo-electron microscopy. Elife, 7. [PMID:30251954]

42. Noreng S, Posert R, Bharadwaj A, Houser A, Baconguis I. (2020) Molecular principles of assembly, activation, and inhibition in epithelial sodium channel. Elife, 9. [PMID:32729833]

43. Palmer LG, Patel A, Frindt G. (2012) Regulation and dysregulation of epithelial Na+ channels. Clin Exp Nephrol, 16 (1): 35-43. [PMID:22038262]

44. Pierandrei S, Truglio G, Ceci F, Del Porto P, Bruno SM, Castellani S, Conese M, Ascenzioni F, Lucarelli M. (2021) DNA Methylation Patterns Correlate with the Expression of SCNN1A, SCNN1B, and SCNN1G (Epithelial Sodium Channel, ENaC) Genes. Int J Mol Sci, 22 (7). [PMID:33916525]

45. Pirahanchi Y, Jessu R, Aeddula NR. (2021) Physiology, Sodium Potassium Pump. StatPearls,. [PMID:30725773]

46. Rauh R, Hoerner C, Korbmacher C. (2017) δβγ-ENaC is inhibited by CFTR but stimulated by cAMP in Xenopus laevis oocytes. Am J Physiol Lung Cell Mol Physiol, 312 (2): L277-L287. [PMID:27941075]

47. Rossier BC, Baker ME, Studer RA. (2015) Epithelial sodium transport and its control by aldosterone: the story of our internal environment revisited. Physiol Rev, 95 (1): 297-340. [PMID:25540145]

48. Rossier BC, Stutts MJ. (2009) Activation of the epithelial sodium channel (ENaC) by serine proteases. Annu Rev Physiol, 71: 361-79. [PMID:18928407]

49. Rotin D, Staub O. (2011) Role of the ubiquitin system in regulating ion transport. Pflugers Arch, 461 (1): 1-21. [PMID:20972579]

50. Saxena A, Hanukoglu I, Saxena D, Thompson RJ, Gardiner RM, Hanukoglu A. (2002) Novel mutations responsible for autosomal recessive multisystem pseudohypoaldosteronism and sequence variants in epithelial sodium channel alpha-, beta-, and gamma-subunit genes. J Clin Endocrinol Metab, 87 (7): 3344-50. [PMID:12107247]

51. Saxena A, Hanukoglu I, Strautnieks SS, Thompson RJ, Gardiner RM, Hanukoglu A. (1998) Gene structure of the human amiloride-sensitive epithelial sodium channel beta subunit. Biochem Biophys Res Commun, 252 (1): 208-13. [PMID:9813171]

52. Sharma S, Hanukoglu A, Hanukoglu I. (2018) Localization of epithelial sodium channel (ENaC) and CFTR in the germinal epithelium of the testis, Sertoli cells, and spermatozoa. J Mol Histol, 49 (2): 195-208. [PMID:29453757]

53. Sharma S, Kumaran GK, Hanukoglu I. (2020) High-resolution imaging of the actin cytoskeleton and epithelial sodium channel, CFTR, and aquaporin-9 localization in the vas deferens. Mol Reprod Dev, 87 (2): 305-319. [PMID:31950584]

54. Shei RJ, Peabody JE, Kaza N, Rowe SM. (2018) The epithelial sodium channel (ENaC) as a therapeutic target for cystic fibrosis. Curr Opin Pharmacol, 43: 152-165. [PMID:30340955]

55. Sheng S, Maarouf AB, Bruns JB, Hughey RP, Kleyman TR. (2007) Functional role of extracellular loop cysteine residues of the epithelial Na+ channel in Na+ self-inhibition. J Biol Chem, 282 (28): 20180-90. [PMID:17522058]

56. Shimkets RA, Warnock DG, Bositis CM, Nelson-Williams C, Hansson JH, Schambelan M, Gill Jr JR, Ulick S, Milora RV, Findling JW et al.. (1994) Liddle's syndrome: heritable human hypertension caused by mutations in the beta subunit of the epithelial sodium channel. Cell, 79 (3): 407-14. [PMID:7954808]

57. Song C, Lee Y, Kim S. (2022) Bioinformatic Analysis for the Prognostic Implication of Genes Encoding Epithelial Sodium Channel in Cervical Cancer. Int J Gen Med, 15: 1777-1787. [PMID:35210842]

58. Waldmann R, Champigny G, Bassilana F, Voilley N, Lazdunski M. (1995) Molecular cloning and functional expression of a novel amiloride-sensitive Na+ channel. J Biol Chem, 270 (46): 27411-4. [PMID:7499195]

59. Ware AW, Harris JJ, Slatter TL, Cunliffe HE, McDonald FJ. (2021) The epithelial sodium channel has a role in breast cancer cell proliferation. Breast Cancer Res Treat, 187 (1): 31-43. [PMID:33630195]

60. Zennaro MC, Hubert EL, Fernandes-Rosa FL. (2012) Aldosterone resistance: structural and functional considerations and new perspectives. Mol Cell Endocrinol, 350 (2): 206-15. [PMID:21664233]

How to cite this page

To cite this family introduction, please use the following:

Database page citation (select format):